Anaesthesia and intensive care
-
Anaesth Intensive Care · Oct 2003
Incident reporting in anaesthesia: a survey of practice in New Zealand.
A postal survey of anaesthetists practising in New Zealand assessed their practice and attitudes to anaesthetic incident reporting. 136 replies were received (57% response rate). Respondents indicated a high awareness of the Anaesthetic Incident Monitoring Study (AIMS) based incident monitoring yet individual utilization may be declining due to a perception that this system is ineffective. Seventy-five per cent of respondents used AIMS forms in their current institute, whilst 87% had at some time completed an AIMS form. ⋯ Almost half the anaesthetists felt that the AIMS reporting system had changed their practice. Common concerns with the system included a need to simplify the reporting process and to ensure that information is managed to provide a useful outcome. This study suggests that incident reporting in its present form needs to be re-evaluated in light of changing priorities in anaesthesia quality improvement activities.
-
We describe a case of tracheal rupture diagnosed after an apparently routine endotracheal intubation for otherwise uneventful lower abdominal surgery in a 33-year-old woman. Risk factors for tracheal rupture, presenting symptoms and signs, management of tracheal rupture and methods of airway management during the surgical repair of the tracheal laceration are discussed. In this case, "side-by-side" microlaryngoscopy tubes, one endobronchial and the other with the tip in the upper trachea, placed with fibreoptic assistance were used for airway management during the tracheal repair.
-
Anaesth Intensive Care · Oct 2003
Case ReportsTerlipressin infusion in catecholamine-resistant shock.
Catecholamine-resistant shock is not uncommon in intensive care. Bolus dose terlipressin (a vasopressin analogue) has been used successfully in this setting allowing cessation of other vasopressor agents. ⋯ We describe a case report where the use of a continuous terlipressin infusion was associated with a dramatic improvement. To our knowledge there have been no previous reports of the use of terlipressin by continuous infusion for the treatment of catecholamine-resistant shock.
-
Anaesth Intensive Care · Oct 2003
Randomized Controlled Trial Comparative Study Clinical TrialParaesthesiae during needle-through-needle combined spinal epidural versus single-shot spinal for elective caesarean section.
The aim of this study was to compare the incidence of paraesthesiae during spinal needle insertion in a needle-through-needle combined spinal-epidural (CSE) versus a single-shot spinal (SSS) technique. Eighty-nine women presenting for elective caesarean section at a tertiary referral obstetric unit were randomized to receive either needle-through-needle CSE or SSS. Equipment used was a 16 gauge/26 gauge combined spinal-epidural kit and a 26 gauge pencil-point spinal needle with introducer (both Sims Portex, Australia) The presence and distribution of paraesthesiae was recorded by an observer at spinal needle insertion and again on day one postoperatively. ⋯ Seventeen of forty-six (37%) women in the needle-through-needle CSE group and four of forty-three (9%) in the SSS group had paraesthesiae upon spinal needle insertion (P < 0.05, Chi-squared test). No patient had persistent neurological symptoms at postoperative day one. We postulate that the higher incidence of paraesthesiae with needle-through-needle CSE may be related to deeper penetration of the subarachnoid space with this technique.
-
The ability of intensive care to replace or support vital organ function has resulted in some patients surviving for long periods of time without improvement or a terminal event. In patients with no realistic chance of survival, decisions to withdraw or withhold life-sustaining therapies are commonly made. Withdrawal of life support at the patient's request is lawful at common law and, in some states of Australia, by legal statute. ⋯ However much weight is frequently placed on the wishes of the family. Disagreements between family and clinicians over decisions to withdraw therapy are unusual and generally resolve over time. However if disagreement persists, it may be advisable to apply to the courts for a declaratory judgement, given the tenuous legal basis of withdrawal of life-sustaining therapy in Australia and the uncertainty over the courts' view of the role of the patient's family in the decision-making process.